Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY.
Endometrial serous carcinoma (ESC) represents the most aggressive subtype of endometrial carcinoma (EC). According to TCGA, ESC exhibits a genomic profile characterized by frequent TP53 mutations and somatic copy-number alterations (SCNA). Several studies have suggested the intratumor heterogeneity (ITH) role on tumor progression and therapy resistance, highlighting ITH as a challenge for personalized medicine. ITH is described as the coexistence of clonal and subclonal cellular populations within a single tumor. To date, extent and prevalence of ITH in ESC have not been fully evaluated. To address ITH analysis in ESC we performed a descriptive integrated molecular approach using targeted sequencing and MLPA to identify mutations and SCNA patterns, respectively. Eight ESC were examined, selecting three tumor regions per case and their corresponding normal tissue. For targeted sequencing a gene panel of 40 genes based on the TCGA and other survey data was performed. For MLPA different probemixes were used to detect SCNA in 106 genes. Analysis of mutations and SCNA were performed in each sample and comparative analysis of the three tumor regions was also conducted. Targeted sequencing showed that mutations in TP53, PIK3CA and PPP2R1A were ubiquitous in all tumor regions. Moreover, MLPA results demonstrated a high frequency of SCNA, according to the already known presence of genomic instability in ESC. Unlike the homogeneous distribution of somatic mutations, SCNA exhibited ITH affecting targetable genes such as ERBB2. Our study suggests that somatic gene copy-number alterations are the main source of ITH in ESC.